WHO Recommends Young Children Play More, Watch Screens Less, Get Plenty Of Sleep 24/04/2019 by David Branigan For children under five years, increasing active play and reducing sedentary screen-time, while getting sufficient sleep, is critical for healthy physical and cognitive development, which impacts life-long health, according to new World Health Organization guidelines. Image Credits: WHO. Continue reading -> Landmark Malaria Vaccine Launched In Malawi – Kenya, Ghana Next 23/04/2019 by David Branigan The World Health Organization today announced that a new vaccine for malaria, which has been in development for 30 years and recently passed clinical trials, is being introduced as part of the routine childhood immunization programmes of Malawi, soon to be followed by Kenya and Ghana. Image Credits: WHO/M. Nieuwenhof. Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 by Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 by Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> New WHO Digital Health Guidelines Assess “Appropriateness” Of Technology Options 17/04/2019 by David Branigan The World Health Organization’s new guidelines on digital health highlight the value of digital health technologies in helping to close health system gaps, while emphasising that they do not replace investments in health system infrastructure. The guidelines assess the appropriateness of a range of digital health technologies and provide recommendations on making informed investments in […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 by Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 by Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> “Tax The Things That Are Killing Us” To Help Curb NCDs, New Report Recommends 16/04/2019 by David Branigan Raising taxes on tobacco, alcohol and sugary beverage products by more than 50 percent could prevent more than 50 million premature deaths due to noncommunicable diseases (NCDs) over the next 50 years, while yielding over US$ 20 trillion in revenue. That is the conclusion of a report by a global task force headed by philanthropist […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Landmark Malaria Vaccine Launched In Malawi – Kenya, Ghana Next 23/04/2019 by David Branigan The World Health Organization today announced that a new vaccine for malaria, which has been in development for 30 years and recently passed clinical trials, is being introduced as part of the routine childhood immunization programmes of Malawi, soon to be followed by Kenya and Ghana. Image Credits: WHO/M. Nieuwenhof. Continue reading -> PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 by Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 by Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> New WHO Digital Health Guidelines Assess “Appropriateness” Of Technology Options 17/04/2019 by David Branigan The World Health Organization’s new guidelines on digital health highlight the value of digital health technologies in helping to close health system gaps, while emphasising that they do not replace investments in health system infrastructure. The guidelines assess the appropriateness of a range of digital health technologies and provide recommendations on making informed investments in […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 by Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 by Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> “Tax The Things That Are Killing Us” To Help Curb NCDs, New Report Recommends 16/04/2019 by David Branigan Raising taxes on tobacco, alcohol and sugary beverage products by more than 50 percent could prevent more than 50 million premature deaths due to noncommunicable diseases (NCDs) over the next 50 years, while yielding over US$ 20 trillion in revenue. That is the conclusion of a report by a global task force headed by philanthropist […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria 23/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] PATH and Medicines for Malaria Venture (MMV) announce a 5-year, jointly-led initiative, VivAccess, to support countries in the elimination of Plasmodium vivax (P. vivax) malaria. The initiative is part of the larger global effort to support malaria-endemic countries in the adoption and use of new and existing tools, to facilitate well-tolerated and […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 by Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 by Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> New WHO Digital Health Guidelines Assess “Appropriateness” Of Technology Options 17/04/2019 by David Branigan The World Health Organization’s new guidelines on digital health highlight the value of digital health technologies in helping to close health system gaps, while emphasising that they do not replace investments in health system infrastructure. The guidelines assess the appropriateness of a range of digital health technologies and provide recommendations on making informed investments in […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 by Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 by Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> “Tax The Things That Are Killing Us” To Help Curb NCDs, New Report Recommends 16/04/2019 by David Branigan Raising taxes on tobacco, alcohol and sugary beverage products by more than 50 percent could prevent more than 50 million premature deaths due to noncommunicable diseases (NCDs) over the next 50 years, while yielding over US$ 20 trillion in revenue. That is the conclusion of a report by a global task force headed by philanthropist […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 by Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 by Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> New WHO Digital Health Guidelines Assess “Appropriateness” Of Technology Options 17/04/2019 by David Branigan The World Health Organization’s new guidelines on digital health highlight the value of digital health technologies in helping to close health system gaps, while emphasising that they do not replace investments in health system infrastructure. The guidelines assess the appropriateness of a range of digital health technologies and provide recommendations on making informed investments in […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 by Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 by Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> “Tax The Things That Are Killing Us” To Help Curb NCDs, New Report Recommends 16/04/2019 by David Branigan Raising taxes on tobacco, alcohol and sugary beverage products by more than 50 percent could prevent more than 50 million premature deaths due to noncommunicable diseases (NCDs) over the next 50 years, while yielding over US$ 20 trillion in revenue. That is the conclusion of a report by a global task force headed by philanthropist […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EU Health Ministers Meet To Discuss Access To Medicines And Treatment 18/04/2019 by Editorial team European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading -> New WHO Digital Health Guidelines Assess “Appropriateness” Of Technology Options 17/04/2019 by David Branigan The World Health Organization’s new guidelines on digital health highlight the value of digital health technologies in helping to close health system gaps, while emphasising that they do not replace investments in health system infrastructure. The guidelines assess the appropriateness of a range of digital health technologies and provide recommendations on making informed investments in […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 by Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 by Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> “Tax The Things That Are Killing Us” To Help Curb NCDs, New Report Recommends 16/04/2019 by David Branigan Raising taxes on tobacco, alcohol and sugary beverage products by more than 50 percent could prevent more than 50 million premature deaths due to noncommunicable diseases (NCDs) over the next 50 years, while yielding over US$ 20 trillion in revenue. That is the conclusion of a report by a global task force headed by philanthropist […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New WHO Digital Health Guidelines Assess “Appropriateness” Of Technology Options 17/04/2019 by David Branigan The World Health Organization’s new guidelines on digital health highlight the value of digital health technologies in helping to close health system gaps, while emphasising that they do not replace investments in health system infrastructure. The guidelines assess the appropriateness of a range of digital health technologies and provide recommendations on making informed investments in […] Continue reading -> Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 by Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 by Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> “Tax The Things That Are Killing Us” To Help Curb NCDs, New Report Recommends 16/04/2019 by David Branigan Raising taxes on tobacco, alcohol and sugary beverage products by more than 50 percent could prevent more than 50 million premature deaths due to noncommunicable diseases (NCDs) over the next 50 years, while yielding over US$ 20 trillion in revenue. That is the conclusion of a report by a global task force headed by philanthropist […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Huge European Parliament Majority Votes To Adopt The SPC Manufacturing Waiver 17/04/2019 by Editorial team [Medicines for Europe Press Release] BRUSSELS, BELGIUM – 17 APRIL 2019 The European Parliament adopted the SPC manufacturing waiver with a huge majority. The waiver will improve access to medicine and create manufacturing job opportunities for Europe as of July 2022. Medicines for Europe will work with its members to facilitate the practical use of […] Continue reading -> DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 by Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> “Tax The Things That Are Killing Us” To Help Curb NCDs, New Report Recommends 16/04/2019 by David Branigan Raising taxes on tobacco, alcohol and sugary beverage products by more than 50 percent could prevent more than 50 million premature deaths due to noncommunicable diseases (NCDs) over the next 50 years, while yielding over US$ 20 trillion in revenue. That is the conclusion of a report by a global task force headed by philanthropist […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases 17/04/2019 by Editorial team [DNDi Press Release] Geneva, Switzerland and San Francisco, USA – 16 April 2019 Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards program to fast track drug development Image Credits: Atomwise. Continue reading -> “Tax The Things That Are Killing Us” To Help Curb NCDs, New Report Recommends 16/04/2019 by David Branigan Raising taxes on tobacco, alcohol and sugary beverage products by more than 50 percent could prevent more than 50 million premature deaths due to noncommunicable diseases (NCDs) over the next 50 years, while yielding over US$ 20 trillion in revenue. That is the conclusion of a report by a global task force headed by philanthropist […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
“Tax The Things That Are Killing Us” To Help Curb NCDs, New Report Recommends 16/04/2019 by David Branigan Raising taxes on tobacco, alcohol and sugary beverage products by more than 50 percent could prevent more than 50 million premature deaths due to noncommunicable diseases (NCDs) over the next 50 years, while yielding over US$ 20 trillion in revenue. That is the conclusion of a report by a global task force headed by philanthropist […] Continue reading -> Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Europe-Africa partnership spearheads development of next-generation antimalarial drug 16/04/2019 by Editorial team [Medicines for Malaria Venture Press Release] The European & Developing Countries Clinical Trials Partnership (EDCTP) has granted new funding of €10m over five years to support late-stage clinical trials of a next-generation antimalarial combination including KAF156 (ganaplacide). The trials will be conducted in four countries in West and Central Africa: Burkina Faso, Gabon, Mali and […] Continue reading -> Posts navigation Older posts